References
- Abuchowski A McCoy JR Palczuk NC van Es T Davis FF . Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase. J. Biol. Chem.252 (11), 3582–3586 (1977).
- Reddy KR Modi MW Pedder S . Use of peginterferon alfa-2a (40 KD) (Pegasys®) for the treatment of hepatitis C. Adv. Drug Deliv. Rev.54 (4), 571–586 (2002).
- Peters, T . All about Albumin: Biochemistry, Genetics, and Medical Applications. Academic Press, MA, USA (1996).
- Chaudhury C Mehnaz S Robinson JM et al. The major histocompatibility complex-related Fc receptor for IgG (FcRn) binds albumin and prolongs its lifespan. J. Exp. Med.197 (3), 315–322 (2003).
- Koral K Li H Ganesh N Birnbaum MJ Hallows KR Erkan E . Akt recruits Dab2 to albumin endocytosis in the proximal tubule. Am. J. Physiol. Renal Physiol.307 (12), F1380–F1389 (2014).
- Home, P Kurtzhals, P . Insulin detemir: from concept to clinical experience. Expert Opin. Pharmacother.7 (3), 325–343 (2006).
- Desai N Trieu V Yao Z et al. Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel. Clin. Cancer Res.12 (4), 1317–1324 (2006).
- Controlled Release Society . www.controlledreleasesociety.org/meetings/Archives/2014AnnualMeeting/program/Pages/Albumin.aspx.
- Iwao Y Hiraike M Kragh-Hansen U et al. Changes of net charge and α-helical content affect the pharmacokinetic properties of human serum albumin. Biochim. Biophys. Acta1774 (12), 1582–1590 (2007).
- Iwao Y Hiraike M Kragh-Hansen U et al. Altered chain-length and glycosylation modify the pharmacokinetics of human serum albumin. Biochim. Biophys. Acta1794 (4), 634–641 (2009).
- Andersen JT Dalhus B Cameron J et al. Structure-based mutagenesis reveals the albumin-binding site of the neonatal Fc receptor. Nat. Commun.3, 610 (2012).
- Andersen JT Dalhus B Viuff D et al. Extending serum half-life of albumin by engineering neonatal Fc receptor (FcRn) binding. J. Biol. Chem.289 (19), 13492–13502 (2014).
- Kratz F . A clinical update of using albumin as a drug vehicle - a commentary. J. Control. Release190, 331–336 (2014).
- Golor G Bensen-Kennedy D Haffner S et al. Safety and pharmacokinetics of a recombinant fusion protein linking coagulation factor VIIa with albumin in healthy volunteers. J. Thromb. Haemost.11 (11), 1977–1985 (2013).
- Novo Nordisk . Financial Statement for 2013 (2014). www.novonordisk.com/images/investors/investor_presentations/2014/interim_report/PR140130_Fullyear_UK.pdf.
- Celgene Reports Fourth Quarter and Full Year 2013 Operating and Financial Results (2014). http://ir.celgene.com/releasedetail.cfm?releaseid=822091.
- Tumey LN Charati M He T et al. Mild method for succinimide hydrolysis on ADCs: impact on ADC potency, stability, exposure, and efficacy. Bioconjug. Chem.25 (10), 1871–1880 (2014).